心脏性休克死亡率的预测模型:系统性审查和元分析
Gwyneth Weng Yi Ng1,2, Christopher Jer Wei Low1,3, Kai Jie Ng1
1Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore.
Critical care medicine
|November 10, 2025
概括
这次元分析发现,对于预测心脏病性休克患者的死亡率,没有明确的"黄金标准". 在评估的风险分数中,CardShock分数显示了最高的歧视和校准.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 生物统计学 生物统计学
背景情况:
- 心脏性休克 (CS) 是一种危及生命的疾病,需要立即干预.
- 精确预测CS患者的死亡率至关重要,但仍然具有挑战性.
- 现有的风险评分缺乏关于其比较有效性和通用性的共识.
研究的目的:
- 评估现有风险评分的预后能力,以预测心脏性休克死亡率.
- 为了比较各种风险分数在患者人口统计学中的效率,有效性和通用性.
主要方法:
- 在MEDLINE,Embase和Scopus数据库中进行系统的文献搜索.
- 102项研究 (126个队列,89546名患者) 的元分析,包括40个独特的预测模型.
- 在曲线下的积分面积 (AUC) 用于歧视和观察:预期 (O:E) 比率用于校准.
主要成果:
- 大多数包含的风险分数之间没有发现显著的绩效差异.
- 卡德Shock得分显示了最高的聚合歧视 (AUC:0.73) 和最佳校准 (O:E:1.06).
- 新的预测模型显示出潜力,但缺乏通用性;子组分析显示出高变化.
结论:
- 没有一个单一的风险评分是CS死亡率预测的最终"黄金标准".
- 与其他广泛使用的分数相比,CardShock分数提供了更好的区分和校准.
- 需要进一步的研究来开发和验证CS的新型,可概括的风险评分.
相关概念视频
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
623
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
623
01:17Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
902
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
902
01:29Heart Failure II: Pathophysiology
695
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
695